ALLMedicine™ Allergic Conjunctivitis Center
Research & Reviews 307 results
European Annals of Allergy and Clinical Immunology; Sánchez-Hernández MC, Dordal MT et. al.
Jul 28th, 2021 - Objective. The association of allergic conjunctivitis (AC) with rhinitis and/or asthma is poorly understood. The objective of this study was to apply the Consensus Document for Allergic Conjunctivitis (DECA) criteria for the classification of AC t...
Pediatric Allergy and Immunology : Official Publication O... Yavuz ST, Oksel Karakus C et. al.
Jul 27th, 2021 - Childhood allergic rhinitis (AR) is clinically heterogeneous. We aimed to identify distinct phenotypes amongst children with AR using data-driven techniques, and to ascertain their association with patterns of symptoms, allergic sensitization and ...
BMC Ophthalmology; Zalwango C, Ayebare P et. al.
Jul 16th, 2021 - Globally, ocular morbidity has emerged as a major public concern with at least 2.2 billion people having vision impairment or blindness. Prisoners (inmates) tend to have limited access to health care especially eye health, and as a result some con...
Molecular Psychiatry; Vincent C, Gilabert-Juan J et. al.
Jun 27th, 2021 - This large cross-sectional population-based study investigated the relationship between dry eye disease (DED) and health-related quality of life (HR-QoL). Dry eye and HR-QoL were assessed in 78,165 participants (19-94 yrs, 59.2% female) from the D...
JAMA Ophthalmology; Strube YNJ
Jun 11th, 2021 - Drawing Attention to the Burden of Allergic Conjunctivitis in Children and Their Families.|2021|Strube YNJ,|
Drugs 411 results see all →
Clinicaltrials.gov 48 results
Mar 31st, 2020 - This is a single-center, randomized, parallel group, placebo-controlled study to evaluate the effect of BEPREVE compared to a placebo eye drop on the measurement of tear film osmolarity and tear film lipid layer in patients with allergic conjuncti...
Jan 29th, 2020 - A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of PR013 Topical Ophthalmic Drops (0.045% and 0.06%) Compared to Vehicle of PR013 Topical Ophthalmic Drops for the Treatment of Allergic Conjunctivitis Using a Modi...
Dec 20th, 2019 - A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis.
Aug 29th, 2019 - This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.
Jul 11th, 2019 - An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber (EEC)
News 29 results
Jun 15th, 2021 - Allergic conjunctivitis harms quality of life for children and their parents, apparently causing greater day-to-day worries than potentially blinding diseases, researchers report. Parents worry especially that treatments might not be effective, ac...
Jul 12th, 2019 - (Reuters) - Eton Pharmaceuticals Inc said on Friday that the U.S. Food and Drug Administration declined to approve its treatment for conjunctivitis, sending its shares tumbling nearly 20 percent in extended trading. No concerns were raised about t...
Apr 17th, 2019 - Dry eyes should not be dismissed as a minor inconvenience and something quickly remedied with over-the-counter eye drops. Dry eye disease is actually an impressively complex condition that significantly affects patients' quality of life. In fact, ...
Apr 2nd, 2018 - The use of antibiotics in the first 6 months of life was associated with a 14% higher incidence of food allergy but with a 24% higher risk of cow’s milk allergy and egg allergy. Children prescribed antibiotics also had a twofold greater risk of as.
Oct 10th, 2017 - A recent meta-analysis evaluated the risk of intraocular bleeding with newer anticoagulant medications compared with warfarin. A new survey suggests that current therapies to treat allergic conjunctivitis are inadequate. The European Commission re...